DOSSIER · 13F Holders · Q4 2025
LCTX
LINEAGE CELL THERAPEUTICS IN
137 institutions still hold LINEAGE CELL THERAPEUTICS IN as of Q4 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 53566P109·137 13F holders·last filed Dec 31, 2025
AI Holders Summary · Q4 2025
137 institutions reported LCTX in Q4 2025. BROADWOOD CAPITAL INC leads at 47.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 7
117 more holders available. Log in →